By Alanna Durkin, Geoff Mulvihill, Associated Press
While aggressively marketing OxyContin, the Sackler family also sought to profit off the drug abuse crisis its company helped create by exploring selling drugs used to treat addiction and reverse overdoses, state lawyers contend in previously secret parts of their…
By PBS NewsHour
On this edition for Sunday, Jan. 20, no compromise in sight as the government shutdown enters day 30, and troubling details emerge on how Purdue Pharma allegedly marketed prescription painkiller OxyContin. Also, after two decades, a paralyzed outdoorsman designs a…
In June, the state of Massachusetts filed a lawsuit against Purdue Pharma, which manufactures the prescription painkiller OxyContin, alleging that the family controlled-company misled patients about the dangers of the opioid drug. Now, new details about the company’s marketing strategy…
By David Armstrong, Andrew Joseph, STAT
A Kentucky appeals court sided with STAT, upholding a ruling ordering the release of Purdue Pharma records about the marketing of the opioid OxyContin.
By Jenny Gold, Kaiser Health News
After years of aggressively promoting OxyContin as a safe and effective way to combat pain, the company is — equally aggressively — recasting itself as a fundamental player in the response to a crisis that many experts say it helped…
Purdue Pharma L.P., the maker of painkiller OxyContin, will pay $634.5 million in fines for saying the drug is less addictive than other pain medications. The lead prosecutor in the case and a drug safety advocate discuss the plea agreement.
Support Provided By:
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.
Thank you. Please check your inbox to confirm.
Additional Support Provided By: